Litigation Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2022)

BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2022)

Docket		Date Filed	2022-09-12
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Patents	8,147,866; 9,655,843; 9,901,539
Link to Docket	External link to docket

Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2022)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-12-01	14	Answer to Counterclaim	infringement of U.S. Patent Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…judgment that U.S. Patent Nos. 8,147,866 (“the ’866 patent”); 9,655,843 (“the ’843 patent”); and 9,901,539…9,901,539 (“the ’539 patent”) (collectively, “the Patents-in-Suit”). REPLY: Paragraph 1 states legal…9,901,539 (“the ’539 patent”) are not infringed by Defendants’ proposed generic buprenorphine buccal film that… 9. These counterclaims arise under the patent laws of the United States, 35 U.S.C. § 1 et seq	External link to document
2022-09-12	3	ANDA Form	Dates of Expiration of Patents in Suit: U.S. Patent No. 8,147,866: July 23… U.S. Patent No. 9,655,843: July 23, 2027 U.S. Patent No. 9,901,539… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 8/1/2022. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 2/1/… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG	External link to document
2022-09-12	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,147,866 B2 ;9,655,843 B2 ;9,901,539…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 8,147,866 B2 … G ✔ Patents. ( G the patent action involves 35 U.S.C. § 292.): … Arius Two, Inc. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT	External link to document
2022-11-10	8	Counterclaim AND Answer to Complaint	noninfringement of U.S. Patents Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…I FOR PATENT INFRINGEMENT (Infringement of U.S. Patent No. 8,147,866 (“the ’866 patent”) …non-infringement of U.S. Patent Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…II FOR PATENT INFRINGEMENT (Infringement of U.S. Patent No. 9,655,843 (“the ’843 patent”) …III FOR PATENT INFRINGEMENT (Infringement of U.S. Patent No. 9,901,539 (“the ’539 patent”)	External link to document